Marea Eyes Cardioprotective Benefit With ANGPTL4 Inhibition

 
• By Joseph Haas
  
cardiovascular system
Marea hopes ANGPTL4 inhibition can benefit high-risk cardiovascular patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from R&D